RETRACTED: Clinical study of the clinical characteristics and prognosis of 1219 cases of endometrial cancer with lymph node metastasis

Abstract

Keywords

Endometrial cancer lymph node metastasis real-world hospital information system (HIS)electronic medical data

At the request of Sage Publishing and the Journal Editor, the following article has been retracted:

Li Z, Zhang W, Luo Z, Huang J, Li L. Clinical study of the clinical characteristics and prognosis of 1219 cases of endometrial cancer with lymph node metastasis. Human & Experimental Toxicology. 2021;40(10):1601-1611. doi:10.1177/09603271211008506

Sage Publishing was made aware that this article may have been submitted with third-party involvement. When we contacted the authors for comment, they denied any third-party involvement and provided material to prove their authorship. However, we did not find these responses sufficiently addressed the concerns we have on the validity of this article.

This article has been retracted due to our unresolved concerns on the authenticity of the authorship.

L.L. disagrees with the retraction. All other authors did not respond for comment when notified of this retraction.

References

Polan

Rossi

Barber

. Extent of lymphadenectomy and postoperative major complications among women with endometrial cancer treated with minimally invasive surgery. Am J Obstet Gynecol 2019; 220: 263.e1–263.e8.

Pecorelli

Zigliani

Odicino

. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009; 105: 107–108.

Multinu

Casarin

Mariani

. Point/counterpoint: is lymphadenectomy required in endometrial cancer for adequate surgical staging? Oncology (Williston Park) 2017; 31: 390–391, 401.

Chan

Cheung

Huh

, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 2006; 107: 1823–1830.

Guo

Cai

, et al. Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: a meta-analysis. Medicine (Baltimore) 2018; 97: e9520.

Hidaka

Nakashima

Shima

, et al. Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer. Obstet Gynecol Int 2010; 2010: 490219.

Venigalla

Chowdhry

Shalowitz

. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers. Gynecol Oncol 2018; 149: 531–538.

Todo

Takeshita

Okamoto

, et al. Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis. J Gynecol Oncol 2017; 28: e59.

Bogani

Dowdy

Cliby

, et al. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res 2014; 40: 301–311.

10.

Todo

Okamoto

Takeshita

, et al. A patient group at negligible risk of para-aortic lymph node metastasis in endometrial cancer. Gynecol Oncol 2016; 141: 155–159.

11.

Boyraz

Atalay

Salman

, et al. Comparison of Mayo and Milwaukee risk stratification models for predicting lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 2018; 28: 869–874.

12.

Kehoe

Miller

. The role of lymphadenectomy in endometrial cancer. Clin Obstet Gynecol 2011; 54: 235–244.

13.

Volpi

Sozzi

Capozzi

, et al. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience. Int J Gynecol Cancer 2019; 29: 312–319.

14.

Benedetti Panici

Basile

Maneschi

, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100: 1707–1716.

15.

Kitchener

Swart

Qian

, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373: 125–136.